摘要:
This therapeutic agent for chronic obstructive pulmonary disease comprises, an active ingredient, at least one of a 7-aminoquinolinone derivative represented by the general formula (I): wherein R1 represents a hydrogen atom or an alkyl group; R2 and R3 each represents a group selected from a hydrogen atom, an acyl group, an alkyl group and an alkenyl group; and R4 and R5 each represents a group selected from a hydrogen atom, an acyl group, an alkyl group, an alkenyl group and an aralkyl group, and its physiologically acceptable salt.
摘要翻译:用于慢性阻塞性肺疾病的治疗剂包含活性成分,由通式(I)表示的7-氨基喹啉酮衍生物中的至少一种:其中R 1表示氢原子或烷基 ; R 2和R 3各自表示选自氢原子,酰基,烷基和烯基的基团; R 4和R 5各自表示选自氢原子,酰基,烷基,烯基和芳烷基的基团,其生理上可接受的 盐。
摘要:
This therapeutic agent for chronic obstructive pulmonary disease comprises, an active ingredient, at least one of a 7-aminoquinolinone derivative represented by the general formula (I): wherein R1 represents a hydrogen atom or an alkyl group; R2 and R3 each represents a group selected from a hydrogen atom, an acyl group, an alkyl group and an alkenyl group; and R4 and R5 each represents a group selected from a hydrogen atom, an acyl group, an alkyl group, an alkenyl group and an aralkyl group, and its physiologically acceptable salt.
摘要翻译:该慢性阻塞性肺疾病治疗剂包含活性成分,由通式(I)表示的7-氨基喹啉酮衍生物中的至少一种:其中R1表示氢原子或烷基; R2和R3各自表示选自氢原子,酰基,烷基和烯基的基团; R 4和R 5各自表示选自氢原子,酰基,烷基,烯基和芳烷基的基团及其生理学上可接受的盐。
摘要:
The present invention relate to a drug for treating circulatory insufficiency containing a benzopyran derivative represented by the following general formula (I): and/or a physiologically acceptable salt thereof as an active ingredient, wherein R1 is an alkyl group having 1 to 10 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms; and any one of R2, R3, R4 and R5 is a hydroxyl group, an alkoxy group, an alkenyloxy group, an alkoxy group substituted with a hydroxyl group, or an alkoxy group substituted with a carboxy group, and the others are hydrogen atoms.
摘要翻译:本发明涉及含有下列通式(I)表示的苯并吡喃衍生物的循环功能不全药物:和/或其生理学上可接受的盐作为有效成分,其中R1为碳原子数1〜10的烷基 ,或具有2〜10个碳原子的烯基; R 2,R 3,R 4和R 5中的任一个是羟基,烷氧基,烯氧基,被羟基取代的烷氧基或被羧基取代的烷氧基,其它是氢原子。
摘要:
The present invention relate to a drug for treating circulatory insufficiency containing a benzopyran derivative represented by the following general formula (I): and/or a physiologically acceptable salt thereof as an active ingredient, wherein R1 is an alkyl group having 1 to 10 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms; and any one of R2, R3, R4 and R5 is a hydroxyl group, an alkoxy group, an alkenyloxy group, an alkoxy group substituted with a hydroxyl group, or an alkoxy group substituted with a carboxy group, and the others are hydrogen atoms.
摘要翻译:本发明涉及含有下列通式(I)表示的苯并吡喃衍生物的循环功能不全药物:和/或其生理学上可接受的盐作为有效成分,其中R1为碳原子数1〜10的烷基 ,或具有2〜10个碳原子的烯基; R 2,R 3,R 4和R 5中的任一个是羟基,烷氧基,烯氧基,被羟基取代的烷氧基或被羧基取代的烷氧基,其它是氢原子。